Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-073364
Filing Date
2014-02-27
Accepted
2014-02-27 17:11:21
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d649166d10k.htm 10-K 937247
2 EX-21.1 d649166dex211.htm EX-21.1 3467
3 EX-23.1 d649166dex231.htm EX-23.1 1644
4 EX-31.1 d649166dex311.htm EX-31.1 7194
5 EX-31.2 d649166dex312.htm EX-31.2 7186
6 EX-32.1 d649166dex321.htm EX-32.1 4213
13 GRAPHIC g649166g50x21.jpg GRAPHIC 51968
  Complete submission text file 0001193125-14-073364.txt   8833467

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT qdel-20131231.xml EX-101.INS 1322763
8 XBRL TAXONOMY EXTENSION SCHEMA qdel-20131231.xsd EX-101.SCH 69556
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qdel-20131231_cal.xml EX-101.CAL 112030
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qdel-20131231_def.xml EX-101.DEF 252440
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE qdel-20131231_lab.xml EX-101.LAB 687704
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qdel-20131231_pre.xml EX-101.PRE 475173
Mailing Address
Business Address 10165 MCKELLAR CT SAN DIEGO CA 92121 8585521100
QUIDEL CORP /DE/ (Filer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-10961 | Film No.: 14650113
SIC: 2835 In Vitro & In Vivo Diagnostic Substances